These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 25945023)

  • 1. Value of bevacizumab in treatment of colorectal cancer: A meta-analysis.
    Qu CY; Zheng Y; Zhou M; Zhang Y; Shen F; Cao J; Xu LM
    World J Gastroenterol; 2015 Apr; 21(16):5072-80. PubMed ID: 25945023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
    Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
    World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab in combination with first-line chemotherapy in patients with metastatic colorectal cancer: a meta-analysis.
    Hu W; Xu WS; Liao XF; He HJ
    Minerva Chir; 2015 Dec; 70(6):451-8. PubMed ID: 26013763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
    Kozloff M; Yood MU; Berlin J; Flynn PJ; Kabbinavar FF; Purdie DM; Ashby MA; Dong W; Sugrue MM; Grothey A;
    Oncologist; 2009 Sep; 14(9):862-70. PubMed ID: 19726453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of bevacizumab in elderly patients with advanced colorectal cancer: A meta-analysis.
    Chen X; Chen Y; Cai X; Zhang D; Fan L; Qiu H; Zhang B; Guo G
    J Cancer Res Ther; 2017; 13(5):869-877. PubMed ID: 29237919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer.
    Cao Y; Tan A; Gao F; Liu L; Liao C; Mo Z
    Int J Colorectal Dis; 2009 Jun; 24(6):677-85. PubMed ID: 19184059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis.
    Cao D; Zheng Y; Xu H; Ge W; Xu X
    Sci Rep; 2019 Dec; 9(1):20326. PubMed ID: 31889159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a meta-analysis.
    Wang M; Zheng X; Ruan X; Ye B; Cai L; Lin F; Tu J; Jiang F; Li S
    Chin Med J (Engl); 2014; 127(3):538-46. PubMed ID: 24451964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab in the treatment of ovarian cancer: a meta-analysis from four phase III randomized controlled trials.
    Ye Q; Chen HL
    Arch Gynecol Obstet; 2013 Sep; 288(3):655-66. PubMed ID: 23543268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of angiogenesis inhibitors re-challenge in colorectal cancer previously treated with bevacizumab: a meta-analysis of randomized controlled trials.
    Xiong YX; Ren L; Wang ZQ; Huang XW; Zhou YJ
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1489-1494. PubMed ID: 28429359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ahmadizar F; Onland-Moret NC; de Boer A; Liu G; Maitland-van der Zee AH
    PLoS One; 2015; 10(9):e0136324. PubMed ID: 26331473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance based Bevacizumab versus complete stop or continuous therapy after induction therapy in first line treatment of stage IV colorectal cancer: A meta-analysis of randomized clinical trials.
    Tamburini E; Rudnas B; Santelmo C; Drudi F; Gianni L; Nicoletti SV; Ridolfi C; Tassinari D
    Crit Rev Oncol Hematol; 2016 Aug; 104():115-23. PubMed ID: 27338848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension as a predictive biomarker for efficacy of bevacizumab treatment in metastatic colorectal cancer: a meta-analysis.
    Chen C; Sun P; Ye S; Weng HW; Dai QS
    J BUON; 2014; 19(4):917-24. PubMed ID: 25536596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials.
    Roviello G; Bachelot T; Hudis CA; Curigliano G; Reynolds AR; Petrioli R; Generali D
    Eur J Cancer; 2017 Apr; 75():245-258. PubMed ID: 28242502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study.
    Kabbinavar FF; Flynn PJ; Kozloff M; Ashby MA; Sing A; Barr CE; Grothey A
    Eur J Cancer; 2012 May; 48(8):1126-32. PubMed ID: 22424880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).
    Schmoll HJ; Cunningham D; Sobrero A; Karapetis CS; Rougier P; Koski SL; Kocakova I; Bondarenko I; Bodoky G; Mainwaring P; Salazar R; Barker P; Mookerjee B; Robertson J; Van Cutsem E
    J Clin Oncol; 2012 Oct; 30(29):3588-95. PubMed ID: 22965961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials.
    Chen J; Lu Y; Zheng Y
    Drug Des Devel Ther; 2015; 9():4751-60. PubMed ID: 26316712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies.
    Zondor SD; Medina PJ
    Ann Pharmacother; 2004; 38(7-8):1258-64. PubMed ID: 15187215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis.
    Galfrascoli E; Piva S; Cinquini M; Rossi A; La Verde N; Bramati A; Moretti A; Manazza A; Damia G; Torri V; Muserra G; Farina G; Garassino MC;
    Dig Liver Dis; 2011 Apr; 43(4):286-94. PubMed ID: 21146479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of bevacizumab in treating metastatic colorectal cancer: a systematic review and meta-analysis of all randomized clinical trials.
    Dai F; Shu L; Bian Y; Wang Z; Yang Z; Chu W; Gao S
    Clin Drug Investig; 2013 Nov; 33(11):779-88. PubMed ID: 23979925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.